MedPath
NMPA Approval

Cefradine Capsules

国药准字H42022808

September 8, 2020

国药准字H42022808

Drug Information

头孢拉定胶囊

胶囊剂

0.25g(按C16H19N3O4S计)

化学药品

September 8, 2020

Company Information

Applicant Company

湖北省鄂州市葛店经济技术开发区三号路

Manufacturing Company

湖北省鄂州市葛店经济技术开发区三号路润阳路22号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢拉定胶囊 - NMPA 批准文号 | MedPath